End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,790 KRW | +0.46% | -6.89% | -5.48% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drug Development
55.5
%
| 16,828 | 66.4 % | 12,390 | 55.5 % | -26.37% |
Biotechnology
44.5
%
| 8,529 | 33.6 % | 9,929 | 44.5 % | +16.40% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.4
%
| 24,730 | 97.5 % | 22,188 | 99.4 % | -10.28% |
Overseas
0.6
%
| 627 | 2.5 % | 130 | 0.6 % | -79.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Moon-Ki Hong
DFI | Director of Finance/CFO | 50 | - |
Seung-Yong Hwang
CTO | Chief Tech/Sci/R&D Officer | 58 | 14-11-30 |
Ho-Young Lee
HRO | Human Resources Officer | 60 | 13-05-31 |
Seok-Joon Yang
AUD | Comptroller/Controller/Auditor | 59 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seung-Yong Hwang
CTO | Chief Tech/Sci/R&D Officer | 58 | 14-11-30 |
Dong-Gyu Ahn
BRD | Director/Board Member | 63 | - |
Yong-Gyu Shin
CHM | Chairman | 56 | - |
Si-hyung Park
BRD | Director/Board Member | 43 | 20-03-24 |
Hoon Jang
BRD | Director/Board Member | 66 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,711,315 | 4,072,962 ( 52.82 %) | 53,165 ( 0.6894 %) | 52.82 % |
Stock B | 0 | 1,541,850 | 0 | 0 |
Company contact information
Invites Biocore Co., Ltd.
8/F, IT Mirae Tower 33 Digital-ro 9-gil
08511, Seoul
+
http://www.bio-core.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-5.48% | 49.62M | |
-27.70% | 9.87B | |
+27.06% | 2.89B | |
-16.78% | 2.75B | |
-15.31% | 2.13B | |
-21.41% | 1.65B | |
+68.70% | 1.47B | |
+29.75% | 811M | |
-5.02% | 733M | |
-29.39% | 510M |
- Stock Market
- Equities
- A216400 Stock
- Company Invites Biocore Co., Ltd.